Raj Mohan Paspulati MD, Presenter: Research grant from Philips Healthcare

Nghi Co Nguyen MD, PhD, Abstract Co-Author: Research Grant, Koninklijke Philips NV

Karin Anna Herrmann MD, Abstract Co-Author: Consultant, Koninklijke Philips NV

Teaching points 1. PET MR technique and work flow in staging and follow up of patients with Gastrointestinal and Gynecological malignancies 2. Added value of PET MR compared to PET CT in assessment of tumor response to treatment 3. Challenges and pit falls of PET MR in clinical practice  

Table of contents/Outline: Chemotherapy and radiation treatment is effective in only a sub group of patients and it is difficult to predict accurately which patient will benefit from a therapeutic regimen. Assessment of response to a particular therapeutic regimen at an early stage of treatment is crucial. Diagnostic imaging plays a crucial role in the initial staging, treatment monitoring and follow up of Gastrointestinal and Gynecological malignancies. CT, MRI and FDG PET-CT are standard imaging techniques used in these patients. Hybrid PET-MR systems have been recently introduced into clinical practice and its potential role is not yet well established. In this exhibit, we illustrate the PET MR technique, work flow and interpretation challenges of this new imaging modality. On a case based approach, role of PETMR in treatment monitoring of colorectal cancer, pancreatic cancer, cervical, endometrial and ovarian cancer will be discussed.  

http://abstract.rsna.org/uploads/2014/14018084/14018084_js6q.pdf

Paspulati, R, Nguyen, N, Herrmann, K, Role of PET-MR in Assessment of Tumor Response in Gastrointestinal and Gynecological Malignancies.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14018084.html